- Investing Ideas
- /
- U.S. Healthcare Undervalued Stocks Based On Cash Flows
U.S. Healthcare Undervalued Stocks Based On Cash Flows
Results
13
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
13 companies
Alignment Healthcare
Market Cap: US$3.8b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$19.74
7D
10.8%
1Y
319.1%
Lantheus Holdings
Market Cap: US$7.0b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$102.00
7D
6.9%
1Y
69.3%
DexCom
Market Cap: US$25.8b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$66.14
7D
7.3%
1Y
-50.8%
Privia Health Group
Market Cap: US$2.9b
Operates as a national physician-enablement company in the United States.
PRVA
US$24.10
7D
9.7%
1Y
30.0%
TransMedics Group
Market Cap: US$2.7b
A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
TMDX
US$80.58
7D
19.1%
1Y
-12.2%
Pennant Group
Market Cap: US$873.5m
Provides healthcare services in the United States.
PNTG
US$25.37
7D
4.2%
1Y
27.4%
Inspire Medical Systems
Market Cap: US$4.4b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$147.54
7D
4.0%
1Y
-36.3%
GeneDx Holdings
Market Cap: US$2.7b
A genomics company, provides genetic testing services.
WGS
US$96.63
7D
20.8%
1Y
904.5%
Myomo
Market Cap: US$152.3m
A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally.
MYO
US$4.43
7D
1.8%
1Y
49.2%
Spectral AI
Market Cap: US$31.1m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$1.23
7D
4.2%
1Y
-38.2%
Waystar Holding
Market Cap: US$6.4b
Develops a cloud-based software solution for healthcare payments.
WAY
US$37.27
7D
4.2%
1Y
n/a
Establishment Labs Holdings
Market Cap: US$875.2m
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$30.34
7D
-3.1%
1Y
-40.5%
Simulations Plus
Market Cap: US$656.6m
Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
SLP
US$32.65
7D
31.5%
1Y
-28.6%